ISDA

Deposition Date 2011-03-15

Release Date 2011-05-25

Last Version Date 2024-02-21

Entry Detail

PDB ID:

3R30

Keywords:

TRANSFERASE/TRANSFERASE INHIBITOR

Title:

MK2 kinase bound to Compound 2

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

3.20 Å

R-Value Free:

0.33

R-Value Work:

0.27

R-Value Observed:

0.28

Space Group:

F 41 3 2

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:MAP kinase-activated protein kinase 2
Gene (Uniprot):MAPKAPK2
Chain IDs:A
Chain Length:319
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P49137 Pfam ID:PF00069 EC:2.7.11.1

Ligand Molecules

CD2

Primary Citation

Structure-based lead identification of ATP-competitive MK2 inhibitors.

Barf, T, Kaptein, A, Wilde, S, Heijden, R, Someren, R, Demont, D, Schultz-Fademrecht, C, Versteegh, J, Zeeland, M, Seegers, N, Kazemier, B, Kar, B, Hoek, M, Roos, J, Klop, H, Smeets, R, Hofstra, C, Hornberg, J, Oubrie, A.Show

Bioorg.Med.Chem.Lett. 21 3818 3822 (2011)

PMID: 21565500 DOI: 10.1016/j.bmcl.2011.04.018

Abstact

MK2 kinase is a promising drug discovery target for the treatment of inflammatory diseases. Here, we describe the discovery of novel MK2 inhibitors using X-ray crystallography and structure-based drug design. The lead has in vivo efficacy in a short-term preclinical model.

Legend

Protein

Chemical

Disease

Primary Citation of related structures